Summary : For years, researchers interested in treating amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) have struggled to understand why variants…
Drug
-
-
Global Market
Lysogene Provides Update on Efficacy, Safety and Timelines of the AAVance Phase 2/3 Clinical Trial with Gene Therapy LYS-SAF302 for the Treatment of MPSIIIA
by adminby adminSummary : Topline data of the main cohort of AAVance clinical trial expected in Q3 2022 Stabilization or decreased size of white…
-
Global MarketModerna
Moderna Cleared to Bring RSV Vaccine to Pivotal Phase III Trial
by adminby adminSummary : Moderna is poised to begin Phase III of its pivotal clinical trial for its candidate vaccine for respiratory syncytial virus…
-
BayerPharma Science & Research
Bayer delivers on medical innovation fueling transformation of pharma business
by adminby adminSummary : At its annual Pharma Media Day 2022, Bayer presented the latest developments in the ongoing transformation of its pharmaceuticals business,…
-
Global Market
VivoPower International PLC’s Kenshaw Critical Power Business Expands to New Headquarters
by adminby adminSummary : VivoPower International PLC (NASDAQ: VVPR) (“VivoPower,” the “Company”) is pleased to announce that its wholly-owned subsidiary in Australia, Kenshaw Electrical…
-
AstraZenecaIndia
Glenmark inks pact to commercialise AstraZeneca’s asthma drug in Colombian market
by adminby adminSummary : Glenmark Pharmaceuticals on Monday said its subsidiary has inked a pact to commercialise AstraZeneca’s asthma drug Pulmicort Respules in the…
-
RegulatoryU.S FDA
Zydus Pharmaceuticals (USA) Inc gets final US FDA approval to market Roflumilast tablets
by adminby adminSummary: Zydus, being one of the first applicants for Roflumilast Tablets, 500 mcg, is eligible for 180 days of shared generic drug…
-
Synopsis : Rare viral haemorrhagic disease similar to Ebola surface in the East of England. Two people in the UK have been…
-
Global MarketPharma Science & Research
Lilly, Roche Push Back Against CMS Draft Guidance on Aduhelm
by adminby adminSummary The U.S. Centers for Medicare & Medicaid Services (CMS) just completed the open comment period for their draft national coverage decision…
-
India
Subject Expert Committee recommends EUA for BE’s Covid jab Corbevax for 12-18 years age group
by adminby adminSummary : The expert panel of India’s central drug authority on Monday recommended granting restricted Emergency Use Authorisation (EUA) to Biological E’s…